On November 17, 2023, Sarepta Therapeutics Inc (NASDAQ: SRPT) opened at $82.98, higher 0.20% from the last session. During the day, the shares moved up to $85.495 and dropped to $82.77 before settling in for the closing price of $82.98. Price fluctuations for SRPT have ranged from $55.25 to $159.89 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 45.19% over the last five years. Company’s average yearly earnings per share was noted 15.27% at the time writing. With a float of $88.26 million, this company’s outstanding shares have now reached $93.55 million.
The firm has a total of 1162 workers. Let’s measure their productivity. In terms of profitability, gross margin is +80.51, operating margin of -56.83, and the pretax margin is -73.95.
Sarepta Therapeutics Inc (SRPT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sarepta Therapeutics Inc is 5.65%, while institutional ownership is 88.40%. The most recent insider transaction that took place on Nov 03, was worth 3,940,500. In this transaction Director of this company bought 50,000 shares at a rate of $78.81, taking the stock ownership to the 140,000 shares. Before that another transaction happened on Nov 03, when Company’s President & CEO bought 25,225 for $79.36, making the entire transaction worth $2,001,800. This insider now owns 390,307 shares in total.
Sarepta Therapeutics Inc (SRPT) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.23) by $0.77. This company achieved a net margin of -75.40 while generating a return on equity of -107.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.27% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Check out the current performance indicators for Sarepta Therapeutics Inc (SRPT). In the past quarter, the stock posted a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.83, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach 2.87 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Analysing the last 5-days average volume posted by the [Sarepta Therapeutics Inc, SRPT], we can find that recorded value of 1.31 million was lower than the volume posted last year of 1.41 million. As of the previous 9 days, the stock’s Stochastic %D was 81.81%. Additionally, its Average True Range was 5.30.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 40.00%, which indicates a significant decrease from 92.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 206.23% in the past 14 days, which was higher than the 83.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $106.94, while its 200-day Moving Average is $119.86. Now, the first resistance to watch is $84.84. This is followed by the second major resistance level at $86.53. The third major resistance level sits at $87.57. If the price goes on to break the first support level at $82.11, it is likely to go to the next support level at $81.08. Now, if the price goes above the second support level, the third support stands at $79.39.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Key Stats
There are currently 93,547K shares outstanding in the company with a market cap of 7.78 billion. Presently, the company’s annual sales total 933,010 K according to its annual income of -703,490 K. Last quarter, the company’s sales amounted to 331,820 K and its income totaled -40,940 K.